These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25400246)

  • 21. NisC binds the FxLx motif of the nisin leader peptide.
    Abts A; Montalban-Lopez M; Kuipers OP; Smits SH; Schmitt L
    Biochemistry; 2013 Aug; 52(32):5387-95. PubMed ID: 23869662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of the leader sequence for directing lanthionine formation in lacticin 481.
    Patton GC; Paul M; Cooper LE; Chatterjee C; van der Donk WA
    Biochemistry; 2008 Jul; 47(28):7342-51. PubMed ID: 18570437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leader peptide-directed processing of labyrinthopeptin A2 precursor peptide by the modifying enzyme LabKC.
    Müller WM; Ensle P; Krawczyk B; Süssmuth RD
    Biochemistry; 2011 Oct; 50(39):8362-73. PubMed ID: 21905643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans, CH43, and genetic analysis of mutacin I biosynthesis genes.
    Qi F; Chen P; Caufield PW
    Appl Environ Microbiol; 2000 Aug; 66(8):3221-9. PubMed ID: 10919773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans.
    Hillman JD; Novák J; Sagura E; Gutierrez JA; Brooks TA; Crowley PJ; Hess M; Azizi A; Leung K; Cvitkovitch D; Bleiweis AS
    Infect Immun; 1998 Jun; 66(6):2743-9. PubMed ID: 9596742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes.
    Qi F; Chen P; Caufield PW
    Appl Environ Microbiol; 1999 Sep; 65(9):3880-7. PubMed ID: 10473390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy.
    Chen P; Novak J; Kirk M; Barnes S; Qi F; Caufield PW
    Appl Environ Microbiol; 1998 Jul; 64(7):2335-40. PubMed ID: 9647795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans.
    Mota-Meira M; Lacroix C; LaPointe G; Lavoie MC
    FEBS Lett; 1997 Jun; 410(2-3):275-9. PubMed ID: 9237644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans.
    Novák J; Caufield PW; Miller EJ
    J Bacteriol; 1994 Jul; 176(14):4316-20. PubMed ID: 8021218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Much of the microcin J25 leader peptide is dispensable.
    Cheung WL; Pan SJ; Link AJ
    J Am Chem Soc; 2010 Mar; 132(8):2514-5. PubMed ID: 20143810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin.
    Balakrishnan M; Simmonds RS; Carne A; Tagg JR
    FEMS Microbiol Lett; 2000 Feb; 183(1):165-9. PubMed ID: 10650221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid method for extracting the antibiotic mutacin 1140 from complex fermentation medium yeast extract.
    Chaney N; Wilson-Stanford S; Kastrantas J; Dahal N; Smith L
    Can J Microbiol; 2009 Nov; 55(11):1261-6. PubMed ID: 19940934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
    Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
    Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of secondary structure of the leader peptide on modification and processing of bovicin HJ50].
    Zhang J; Tu L; Zhang Z; Lin Y; Chen W; Zhong J
    Wei Sheng Wu Xue Bao; 2012 Aug; 52(8):969-76. PubMed ID: 23173433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.
    Smith L; Novák J; Rocca J; McClung S; Hillman JD; Edison AS
    Eur J Biochem; 2000 Dec; 267(23):6810-6. PubMed ID: 11082191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genes involved in the repression of mutacin I production in Streptococcus mutans.
    Nguyen T; Zhang Z; Huang IH; Wu C; Merritt J; Shi W; Qi F
    Microbiology (Reading); 2009 Feb; 155(Pt 2):551-556. PubMed ID: 19202103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
    Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
    Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttranslational Peptide-Modification Enzymes in Action: Key Roles for Leaders and Glutamate.
    Montalbán-López M; Kuipers OP
    Cell Chem Biol; 2016 Mar; 23(3):318-9. PubMed ID: 26991100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.